应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03347 泰格医药
未开盘 02-27 16:08:20
47.060
-0.320
-0.68%
最高
48.300
最低
46.600
成交量
78.96万
今开
47.380
昨收
47.380
日振幅
3.59%
总市值
405.19亿
流通市值
57.94亿
总股本
8.61亿
成交额
3,716万
换手率
0.64%
流通股本
1.23亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
医药行业周报:哮喘与COPD:长效化、生物药加速突破
中信建投证券 · 03-01 00:00
医药行业周报:哮喘与COPD:长效化、生物药加速突破
每日卖空追踪 | 泰格医药 02月27日卖空量成交8.77万股,卖空比例为11.11%
市场透视 · 02-27 16:30
每日卖空追踪 | 泰格医药 02月27日卖空量成交8.77万股,卖空比例为11.11%
港股异动 | 创新药板块走弱,百济神州跌近9%,药明生物跌超7%
老虎资讯综合 · 02-26
港股异动 | 创新药板块走弱,百济神州跌近9%,药明生物跌超7%
节后A股首个交易日 年轻人的“药理财”表现如何?
21世纪经济报道 · 02-24
节后A股首个交易日 年轻人的“药理财”表现如何?
每日卖空追踪 | 泰格医药 02月24日卖空量成交5.84万股,卖空比例为4.61%
市场透视 · 02-24
每日卖空追踪 | 泰格医药 02月24日卖空量成交5.84万股,卖空比例为4.61%
泰格医药02月24日主力净流出186.6万元 散户资金买入
市场透视 · 02-24
泰格医药02月24日主力净流出186.6万元 散户资金买入
盈利上行但现金流告急,CRO新秀博纳西亚能否“后来居上”?
智通财经 · 02-24
盈利上行但现金流告急,CRO新秀博纳西亚能否“后来居上”?
每日卖空追踪 | 泰格医药 02月20日卖空量成交3.87万股,卖空比例为9.76%
市场透视 · 02-20
每日卖空追踪 | 泰格医药 02月20日卖空量成交3.87万股,卖空比例为9.76%
泰格医药02月20日主力净流出45.8万元 散户资金买入
市场透视 · 02-20
泰格医药02月20日主力净流出45.8万元 散户资金买入
每日卖空追踪 | 泰格医药 02月16日卖空量成交5.07万股,卖空比例为25.57%
市场透视 · 02-16
每日卖空追踪 | 泰格医药 02月16日卖空量成交5.07万股,卖空比例为25.57%
泰格医药02月16日获主力加仓86.3万元
市场透视 · 02-16
泰格医药02月16日获主力加仓86.3万元
东吴证券:给予泰格医药买入评级
证券之星 · 02-15
东吴证券:给予泰格医药买入评级
每日卖空追踪 | 泰格医药 02月13日卖空量成交6.28万股,卖空比例为2.96%
市场透视 · 02-13
每日卖空追踪 | 泰格医药 02月13日卖空量成交6.28万股,卖空比例为2.96%
创新药退潮,博纳西亚赴港,一场“效率型外包”的暗战打响
港股研究社 · 02-12
创新药退潮,博纳西亚赴港,一场“效率型外包”的暗战打响
每日卖空追踪 | 泰格医药 02月12日卖空量成交8.63万股,卖空比例为3.07%
市场透视 · 02-12
每日卖空追踪 | 泰格医药 02月12日卖空量成交8.63万股,卖空比例为3.07%
里昂:降泰格医药(03347)目标价至59.9港元 续予“跑赢大市”评级
智通财经 · 02-12
里昂:降泰格医药(03347)目标价至59.9港元 续予“跑赢大市”评级
港股异动 | 泰格医药(03347)尾盘跌超5% 扣非利润下跌逾四成 机构称股价已反映利好因素
智通财经 · 02-12
港股异动 | 泰格医药(03347)尾盘跌超5% 扣非利润下跌逾四成 机构称股价已反映利好因素
扣非归母净利润下跌逾40%,泰格医药(03347)何以在二级市场量价齐升?
智通财经 · 02-10
扣非归母净利润下跌逾40%,泰格医药(03347)何以在二级市场量价齐升?
港股异动 | CRO概念股涨幅居前 创新药投融资与BD出海同步回暖 行业景气度有望逐步改善
智通财经 · 02-10
港股异动 | CRO概念股涨幅居前 创新药投融资与BD出海同步回暖 行业景气度有望逐步改善
恒生医疗保健指数升2.17% 医药板块普遍拉升 机构持续看好中国创新药出海的产业趋势
金吾财讯 · 02-10
恒生医疗保健指数升2.17% 医药板块普遍拉升 机构持续看好中国创新药出海的产业趋势
加载更多
公司概况
公司名称:
泰格医药
所属市场:
SEHK
上市日期:
--
主营业务:
杭州泰格医药科技股份有限公司是一家从事为新药研发提供临床试验服务的中国控股公司。该公司经营两个分部。临床试验技术服务分部向生物制药和医疗器械公司提供临床试验运作服务和医学翻译等服务,帮助其进行创新药物、仿制药和医疗器械的临床试验。临床试验相关服务及实验室服务分部从事提供分析服务,比如数据管理和统计分析;后勤和执行支持服务,比如临床试验现场管理;行政协助,比如患者招募;以及咨询服务等。该分部同时通过其子公司为临床前和临床开发阶段提供实验室服务。该公司在国内市场和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":47.06,"timestamp":1772179700006,"preClose":47.38,"halted":0,"volume":789649,"delay":0,"changeRate":-0.006753904601097515,"floatShares":123124800,"shares":861000000,"eps":0.5337005264808963,"marketStatus":"未开盘","change":-0.32,"latestTime":"02-27 16:08:20","open":47.38,"high":48.3,"low":46.6,"amount":37155257,"amplitude":0.03588,"askPrice":47.06,"askSize":2000,"bidPrice":46.8,"bidSize":5400,"shortable":3,"etf":0,"ttmEps":0.811924854648434,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":0,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":47.38,"dividendRate":0.006946,"openAndCloseTimeList":[[1772155800000,1772164800000],[1772168400000,1772179200000]],"volumeRatio":0.7582169642259357,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":59.64,"timestamp":1772175600000,"preClose":60.5,"halted":0,"volume":6184200,"delay":0,"premium":"-30.59"}},"requestUrl":"/m/hq/s/03347","defaultTab":"news","newsList":[{"id":"2616826552","title":"医药行业周报:哮喘与COPD:长效化、生物药加速突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2616826552","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616826552?lang=zh_cn&edition=full","pubTime":"2026-03-01 00:00","pubTimestamp":1772294400,"startTime":"0","endTime":"0","summary":"核心观点:哮喘与COPD的异质性决定了2型炎症通路的精准分层与生物标志物驱动的个体化治疗是生物制剂价值兑现的前提;行业呈现“单靶点长效化”与“多靶点协同”的技术迭代趋势,同时COPD异质性催生出PDE3/4吸入制剂与生物制剂并行的双主线格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06978","BK1583","BK1576","BK1141","03347","02359","02269","BK1574"],"gpt_icon":0},{"id":"2614889463","title":"每日卖空追踪 | 泰格医药 02月27日卖空量成交8.77万股,卖空比例为11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614889463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614889463?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181035,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月27日,跌0.68%,卖空量成交8.77万股,较上一交易日减少70.79%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163502a436797c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163502a436797c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03347","BK1576","BK1583"],"gpt_icon":0},{"id":"1167195569","title":"港股异动 | 创新药板块走弱,百济神州跌近9%,药明生物跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167195569","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167195569?lang=zh_cn&edition=full","pubTime":"2026-02-26 15:33","pubTimestamp":1772091221,"startTime":"0","endTime":"0","summary":"泰格医药、康龙化成跌超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7aeeed2b7873496584fe7f3c4e94617c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","03759","03347","06160"],"gpt_icon":0},{"id":"2614747108","title":"节后A股首个交易日 年轻人的“药理财”表现如何?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614747108","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614747108?lang=zh_cn&edition=full","pubTime":"2026-02-24 20:38","pubTimestamp":1771936713,"startTime":"0","endTime":"0","summary":"2月24日,A股节后首个交易日,医药商业板块和医疗器械板块领涨,分别上涨1.28%和0.66%,化学制药上涨0.50%,拉长时间线看,创新药、CXO、高端医疗器械等板块正加速复苏。这一表现,也将创下公司上市以来归母净利润的历史新高。昔日“疫苗之王”智飞生物,自上市以来首次年报亏损。目前,智飞生物的代理产品收入占比高达90%,其代理的默沙东HPV疫苗业务缩水,是其业绩下滑的关键因素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224211742a71a1893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224211742a71a1893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","LU0320764599.SGD","BK1161","LU0708995583.HKD","LU2242644610.SGD","BK1576","01877","BK1574","06978","LU2045819591.USD","BK1141","06127","03347","09995","BK1583","LU1046422090.SGD","LU2125910500.SGD","02315","02359","LU0052750758.USD"],"gpt_icon":0},{"id":"2614771348","title":"每日卖空追踪 | 泰格医药 02月24日卖空量成交5.84万股,卖空比例为4.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614771348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614771348?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:30","pubTimestamp":1771921833,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月24日,跌3.6%,卖空量成交5.84万股,较上一交易日增加42.79%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163539a4c2370f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163539a4c2370f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","03347","BK1583"],"gpt_icon":0},{"id":"2614715847","title":"泰格医药02月24日主力净流出186.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614715847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614715847?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:15","pubTimestamp":1771920952,"startTime":"0","endTime":"0","summary":"02月24日, 泰格医药股价跌3.60%,报收47.62元,成交金额6030.9万元,换手率1.03%,振幅4.13%,量比0.98。泰格医药今日主力资金净流出186.6万元,上一交易日主力净流出0万元。该股近5个交易日下跌10.82%,主力资金累计净流入1320.8万元;近20日主力资金累计净流入4444.9万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224162054a7190cf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224162054a7190cf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1141","BK1576","03347"],"gpt_icon":0},{"id":"2614771395","title":"盈利上行但现金流告急,CRO新秀博纳西亚能否“后来居上”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614771395","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614771395?lang=zh_cn&edition=full","pubTime":"2026-02-24 14:59","pubTimestamp":1771916373,"startTime":"0","endTime":"0","summary":"2025年业绩回暖 毛利率稳步上行财务数据显示,博纳西亚的业绩在经历2024年的短暂回调后,于2025年重回增长轨道。据招股书披露,就2024年来自临床CRO服务的收入而言,博纳西亚在总部位于中国的市场参与者中排名第14位,市场份额为0.7%。现金流压力较大,或是公司急于上市补血的重要原因。整体来看,博纳西亚细分赛道布局清晰,走的是“小而美”的专家路线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224150431a4c1d5a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224150431a4c1d5a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","03347","BK1161","06978","BK1141","BK1576"],"gpt_icon":0},{"id":"2613159290","title":"每日卖空追踪 | 泰格医药 02月20日卖空量成交3.87万股,卖空比例为9.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613159290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613159290?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576233,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月20日,跌1.65%,卖空量成交3.87万股,较上一交易日减少23.67%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163439a4b5e92b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163439a4b5e92b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","03347","BK1583"],"gpt_icon":0},{"id":"2613160290","title":"泰格医药02月20日主力净流出45.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2613160290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613160290?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:15","pubTimestamp":1771575308,"startTime":"0","endTime":"0","summary":"02月20日, 泰格医药股价跌1.65%,报收48.80元,成交金额1947.3万元,换手率0.32%,振幅4.80%,量比0.15。泰格医药今日主力资金净流出45.8万元,上一交易日主力净流入404.0万元。该股近5个交易日下跌12.97%,主力资金累计净流入1784.3万元;近20日主力资金累计净流入3758.4万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161518a4b5da51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161518a4b5da51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","BK1583","03347"],"gpt_icon":0},{"id":"2612548726","title":"每日卖空追踪 | 泰格医药 02月16日卖空量成交5.07万股,卖空比例为25.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612548726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612548726?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230630,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月16日,涨1.18%,卖空量成交5.07万股,较上一交易日减少63.42%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163426a700dfc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163426a700dfc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1576","03347","BK1141"],"gpt_icon":0},{"id":"2611101717","title":"泰格医药02月16日获主力加仓86.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611101717","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611101717?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:15","pubTimestamp":1771229734,"startTime":"0","endTime":"0","summary":"02月16日, 泰格医药股价涨1.18%,报收49.62元,成交金额973.3万元,换手率0.16%,振幅4.77%,量比0.08。泰格医药今日主力资金净流入86.3万元,连续3日净流入,上一交易日主力净流入404.0万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为41.18%,平均涨幅为7.03%。该股近5个交易日下跌7.77%,主力资金累计净流入1916.3万元;近20日主力资金累计净流入3890.4万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161709a4a9ed26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161709a4a9ed26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","BK1583","03347"],"gpt_icon":0},{"id":"2611429171","title":"东吴证券:给予泰格医药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2611429171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611429171?lang=zh_cn&edition=full","pubTime":"2026-02-15 09:10","pubTimestamp":1771117827,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对泰格医药进行研究并发布了研究报告《泰格医药:临床CRO龙头,扬帆启航新征程》,给予泰格医药买入评级。国内临床CRO行业经历激烈的价格竞争,供给优化,泰格医药龙头市占率持续提升,新签订单加速,有望迎来量价齐升,业绩修复增长潜力大。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级5家;过去90天内机构目标均价为77.88。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500001037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","300347","601555"],"gpt_icon":0},{"id":"2611116423","title":"每日卖空追踪 | 泰格医药 02月13日卖空量成交6.28万股,卖空比例为2.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611116423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611116423?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:30","pubTimestamp":1770971436,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月13日,跌3.37%,卖空量成交6.28万股,较上一交易日减少77.21%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163525a6f6e664&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163525a6f6e664&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1583","BK1141","BK1576"],"gpt_icon":0},{"id":"2610268279","title":"创新药退潮,博纳西亚赴港,一场“效率型外包”的暗战打响","url":"https://stock-news.laohu8.com/highlight/detail?id=2610268279","media":"港股研究社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610268279?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:52","pubTimestamp":1770886343,"startTime":"0","endTime":"0","summary":"当中国创新药管线数量持续增长、药企数量快速增加,而真正具备大规模临床执行能力的企业却有限时,CRO的角色自然从“辅助服务商”转向“效率中枢”。博纳西亚,正是在这种结构变化中出现的样本。博纳西亚的策略也印证了这一点。这也是博纳西亚选择赴港上市的真正动因。但无论结果如何,博纳西亚的出现已经说明一个事实:中国CRO行业正在进入新的阶段。创新药退潮,并没有让医药产业降温,只是把价值重新分配给更能提高效率的人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212171215a49bc96a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212171215a49bc96a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1141","02359","BK1583","BK1576","BK1161","03759","06978","03347"],"gpt_icon":0},{"id":"2610841926","title":"每日卖空追踪 | 泰格医药 02月12日卖空量成交8.63万股,卖空比例为3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610841926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610841926?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:30","pubTimestamp":1770885035,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月12日,跌5.32%,卖空量成交8.63万股,较上一交易日减少88.53%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163502a6f28d4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163502a6f28d4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1583","BK1576","BK1141"],"gpt_icon":0},{"id":"2610912794","title":"里昂:降泰格医药(03347)目标价至59.9港元 续予“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2610912794","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610912794?lang=zh_cn&edition=full","pubTime":"2026-02-12 15:29","pubTimestamp":1770881373,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,里昂发布研报称,下调泰格医药(03347) 2027财年盈测7%,以反映长期投资收益的不确定因素增加。该行续予泰格医药“跑赢大市”评级,当中将H股目标价由68.2港元下调至59.9港元,并将泰格医药(300347.SZ)A股目标价由81.9元人民币降至72元人民币。泰格医药的订单情况有所改善,但市场更关注公司的订单转化收入效率及投资变现能力。由于短期利好因素已反映在股价,相信其风险与回报已趋于平衡。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","300347"],"gpt_icon":0},{"id":"2610691478","title":"港股异动 | 泰格医药(03347)尾盘跌超5% 扣非利润下跌逾四成 机构称股价已反映利好因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2610691478","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610691478?lang=zh_cn&edition=full","pubTime":"2026-02-12 15:12","pubTimestamp":1770880368,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,泰格医药尾盘跌超5%,截至发稿,跌4.85%,报51港元,成交额1.3亿港元。消息面上,泰格医药近日公告,此预计2025年实现营业收入66.6亿-76.8亿元,同比增长1%至16%;归属于上市公司股东的净利润为8.3亿-12.3亿元,同比增长105%至204%;归属于上市公司股东的扣除非经常性损益后的净利润约3.3亿-4.9亿元,同比下降61%至43%。该行下调泰格医药2027财年盈测7%,以反映长期投资收益的不确定因素增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","VXUS","BK0174","LU1820825898.SGD","LU1146622755.USD","BK4585","BK0077","BK4588","03347","BK0028","BK1141","VT","300347","BK1576","BK1583"],"gpt_icon":0},{"id":"2610613952","title":"扣非归母净利润下跌逾40%,泰格医药(03347)何以在二级市场量价齐升?","url":"https://stock-news.laohu8.com/highlight/detail?id=2610613952","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610613952?lang=zh_cn&edition=full","pubTime":"2026-02-10 14:21","pubTimestamp":1770704466,"startTime":"0","endTime":"0","summary":"近日, 泰格医药的股价出现了一波明显的止跌反弹的趋势。但之后,泰格医药股价又迎来近半个月的技术性下跌,于1月28日跌破50港元。而导致这一盘面变化的根本原因或在于泰格医药披露的2025年年报业绩预告。并且当日是一个典型的“量价齐升”走势,泰格医药当日股票成交量达到704.77万股,展示出场外持币投资者较为强烈的买入意愿。而这已初步反映在了泰格医药此次披露的业绩预告中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","300347"],"gpt_icon":0},{"id":"2610699139","title":"港股异动 | CRO概念股涨幅居前 创新药投融资与BD出海同步回暖 行业景气度有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2610699139","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610699139?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:55","pubTimestamp":1770692111,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,CRO概念股涨幅居前,截至发稿,维亚生物涨6.14%,报2.42港元;药明生物涨6.01%,报40.54港元;泰格医药涨4.65%,报56.3港元;药明康德涨4.31%,报121港元。消息面上,2025年药明康德净利润预计同比增加103%,泰格医药同比增加105-204%。国泰海通证券发布研报称,随着融资与BD回款回升,药企重新加大临床试验投入,对临床CRO、SMO及注册服务的外包需求同步恢复,为行业景气度回升提供直接资金来源与项目基础。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0856984785.SGD","159992","02269","01873","BK1583","LU0359201612.USD","LU0417516738.SGD","LU0456846285.SGD","LU0320764599.SGD","LU1880383366.USD","BK1141","06978","LU2125910500.SGD","SG9999002463.SGD","LU0043850808.USD","LU1242518931.SGD","VXUS","IE00B0JY6N72.USD","LU1720050803.USD","LU2045819591.USD","SG9999002562.SGD","BK1521","LU0181495838.USD","BK1574","LU0819121731.USD","LU1688375341.USD","LU0516422440.USD","LU0516423091.SGD","03347","LU0348735423.USD","LU2039709279.SGD","LU0348825331.USD","LU0516422366.SGD","BK1161","LU0516422952.EUR","LU0823426308.USD","BK4588","LU0572944931.SGD","LU0359202008.SGD","02359","LU1794554557.SGD","BK1589","LU0326950275.SGD","LU2242644610.SGD","BK1610","LU0052750758.USD","LU0823426480.USD","LU0051755006.USD","LU0516423174.USD","VT"],"gpt_icon":0},{"id":"2610268695","title":"恒生医疗保健指数升2.17% 医药板块普遍拉升 机构持续看好中国创新药出海的产业趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2610268695","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610268695?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:59","pubTimestamp":1770688793,"startTime":"0","endTime":"0","summary":"2月8日,信达生物宣布与礼来制药达成战略合作,携手推进肿瘤及免疫领域创新药物的全球研发。2026年,继续看好中国创新药出海的产业趋势,继续重点跟踪ADC、双抗、小核酸、减肥药等核心优势赛道的投资机会,期待JPM大会、ASCO等带来数据更新和BD催化。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8f73ea90e21e93e4b02cf2f8986a9c30","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","159938","LU0502904849.HKD","09688","LU0572944931.SGD","LU1961090484.USD","LU0181495838.USD","03347","02359","BK1161","LU0051755006.USD","01877","02696","09995","02269","02162","LU0043850808.USD","LU0196878994.USD","LU0634319403.HKD","LU1720050803.USD","LU2476274308.USD","LU0417516738.SGD","LU0359202008.SGD","01548","09939","09926","LU0140636845.USD","06990","159992","LU2045819591.USD","BK1587","LU2476274720.SGD","LU0516423174.USD","LU1046422090.SGD","06978","LU0856984785.SGD","LU2488822045.USD","LU2242644610.SGD","LU1969619763.USD","LU0417516902.SGD","LU0516422366.SGD","LU0823426308.USD","159506","HK0000306701.USD","LU2039709279.SGD","01801","09969","LU0348825331.USD","LU1688375341.USD","IE00B5MMRT66.SGD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.tigermed.net","stockEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0151},{"period":"3month","weight":0.1944},{"period":"6month","weight":0.0116},{"period":"1year","weight":0.3051},{"period":"ytd","weight":0.1063}],"compareEarnings":[{"period":"1week","weight":0.0082},{"period":"1month","weight":-0.043},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0619},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.039}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州泰格医药科技股份有限公司是一家从事为新药研发提供临床试验服务的中国控股公司。该公司经营两个分部。临床试验技术服务分部向生物制药和医疗器械公司提供临床试验运作服务和医学翻译等服务,帮助其进行创新药物、仿制药和医疗器械的临床试验。临床试验相关服务及实验室服务分部从事提供分析服务,比如数据管理和统计分析;后勤和执行支持服务,比如临床试验现场管理;行政协助,比如患者招募;以及咨询服务等。该分部同时通过其子公司为临床前和临床开发阶段提供实验室服务。该公司在国内市场和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.03226},{"month":2,"riseRate":0.5,"avgChangeRate":0.003406},{"month":3,"riseRate":0.6,"avgChangeRate":-0.015344},{"month":4,"riseRate":0.2,"avgChangeRate":-0.055126},{"month":5,"riseRate":0.4,"avgChangeRate":0.024418},{"month":6,"riseRate":0.6,"avgChangeRate":0.024718},{"month":7,"riseRate":0.6,"avgChangeRate":0.079529},{"month":8,"riseRate":0,"avgChangeRate":-0.091864},{"month":9,"riseRate":0.333333,"avgChangeRate":0.032065},{"month":10,"riseRate":0.5,"avgChangeRate":-0.02594},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.001375},{"month":12,"riseRate":0.5,"avgChangeRate":0.041249}],"exchange":"SEHK","name":"泰格医药","nameEN":"TIGERMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,03347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}